Compounds > dehydroepiandrosterone
Page last updated: 2024-08-17

dehydroepiandrosterone and oxythiamine

dehydroepiandrosterone has been researched along with oxythiamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haines, GK1
Boros, LG; Brandes, JL; Cascante, M; Comin, B; Creppy, E; Ennamany, R; Lee, WN; Puigjaner, J; Raïs, B; Saboureau, D1
Bassilian, S; Cascante, M; Centelles, JJ; Ciudad, CJ; Kazhyna, MV; Lee, WN; Lim, S; Noé, V; Ramos-Montoya, A; Trebukhina, RV1

Other Studies

3 other study(ies) available for dehydroepiandrosterone and oxythiamine

ArticleYear
Correspondence re: L. G. Boros et al., oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res., 57: 4242-4248, 1997.
    Cancer research, 1998, Jul-15, Volume: 58, Issue:14

    Topics: Antimetabolites; Breast Neoplasms; Carcinoma; Cell Division; DEAD-box RNA Helicases; Dehydroepiandrosterone; Humans; Molecular Weight; Neoplasm Proteins; Nuclear Proteins; Oxythiamine; Protein Kinases; Ribose; RNA Helicases; Species Specificity

1998
Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle.
    FEBS letters, 1999, Jul-30, Volume: 456, Issue:1

    Topics: Animals; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Death; Cell Division; Dehydroepiandrosterone; Dose-Response Relationship, Drug; G1 Phase; Heart; Kidney; Liver; Mice; Mice, Inbred C57BL; Myocardium; Oxythiamine; Pentoses; Transketolase

1999
Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer.
    International journal of cancer, 2006, Dec-15, Volume: 119, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Growth Inhibitors; HT29 Cells; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Nucleic Acid Synthesis Inhibitors; Oxidation-Reduction; Oxythiamine; Pentose Phosphate Pathway; Ribosemonophosphates

2006